Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma-Reference-Cited by-同舟云学术

Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma

Published:2019-03 Issue:7748 Volume:567 Page:341-346
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Shi Yufeng,Lim S. Kyun,Liang Qiren,Iyer Swathi V.,Wang Hua-Yu,Wang Zilai,Xie Xuanhua,Sun Daochun,Chen Yu-Jung,Tabar Viviane,Gutin Philip,Williams Noelle,De Brabander Jef K.,Parada Luis F.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-0993-x.pdf

Reference50 articles.

1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005).

2. Wen, P. Y. & Kesari, S. Malignant gliomas in adults. N. Engl. J. Med. 359, 492–507 (2008).

3. Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522–526 (2012).

4. Viale, A. & Draetta, G. F. Metabolic features of cancer treatment resistance. Recent Results Cancer Res. 207, 135–156 (2016).

5. Viale, A. et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514, 628–632 (2014).

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deoxyarbutin targets mitochondria to trigger p53-dependent senescence of glioblastoma cells;Free Radical Biology and Medicine;2024-11

2. The mitochondrial stress-induced protein carboxyl-terminal alanine and threonine tailing (msiCAT-tailing) promotes glioblastoma tumorigenesis by modulating mitochondrial functions;2024-09-02

3. The mitochondrial stress-induced protein carboxyl-terminal alanine and threonine tailing (msiCAT-tailing) promotes glioblastoma tumorigenesis by modulating mitochondrial functions;2024-09-02

4. Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy;Acta Pharmaceutica Sinica B;2024-09

5. Y9, a Gboxin analog, displays anti-tumor effect in non-small cell lung cancer by inducing lysosomal dysfunction and apoptosis;Bioorganic Chemistry;2024-09